An Orphan Drug Status Granted for the Leading Telormedix’s Cancer Treatment
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer…
08/12/2014 - 2 minutes
Julie Lellouche
Blogger for Labiotech.eu. Entrepreneurial Student at SupBiotech, Paris Higher Biotechnology Institute.
Alizé Pharma Acquires Exclusive Worldwide Rights on a New Peptide to Tackle Bone Diseases
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat…
06/12/2014 - 2 minutes
Forbion Capital Partners: a Leading European Biotech VC is rising!
Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, sold PneumRx of…
05/12/2014 - 3 minutes
New Technologies Against Allergies are on the Wave
Anergis, a company developing proprietary ultra-fast allergy vaccines, closed a Series B financing round totaling 12,1…
03/12/2014 - 2 minutes
Ascendis Pharma Closed €48M for an Innovative Weekly Hormone Injection
Ascendis Pharma, a biotechnology company that applies its innovative TransCon technology to address significant unmet medical…
02/12/2014 - 2 minutes
The First Gene Therapy Drug Will Be Sold at Record €1,1M Price
What could you buy with €1,1M euros? A house? Or a single prescription for a new…
01/12/2014 - 3 minutes
One Billion Strategic Oncology Alliance for the Second Largest Antibody Technology Platform
Oxford BioTherapeutics and Menarini Group have initiated the first-in-human clinical study of OBT357, a novel enhanced…
28/11/2014 - 2 minutes
Curetis Raised Additional €14.5M to Diagnose Severe Infectious Diseases
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
27/11/2014 - 2 minutes
The Highest Ever Bioavailable Curcumin is Coming in Europe
Theravalues Corporation, Tokyo based company, will launch Theracurmin® Super for the European market at Hi Europe 2014,…
26/11/2014 - 2 minutes
Promethera Biosciences Raised €25,33M to Treat Liver Diseases
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…
25/11/2014 - 2 minutes
Will New Actavis-Allergan Entity Lead to Be in the World Top 10 Drugmakers Companies?
The US pharmaceutical company Allergan, known for their Botox, agreed an Actavis bid of 53…
24/11/2014 - 2 minutes
Munich: Why is it One of the Best Biotech Cluster in Europe ?
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue…
23/11/2014 - 3 minutes
